Molecular Biology Laboratory
(MBL)
Pharmacogenetic study and biomarker discovery in clinical trials, in vitro studies of pharmacoki-
netic drug interactions, multidrug resistance and regulatory mechanisms 

Early Clinical Pharmacological
Trial Unit (KliPS)
The Phase I Unit plans and conducts German
Medicinal Products Act (AMG) Phase 0, I and II
trials with adult patients or healthy volunteers 

Analytical Chemistry Laboratory
(ACL)
Development of highly sensitive detection methods for the quantification of drugs and their metabolites as well as endogenous substances in patient samples and samples from clinical drug trials 

Cooperation Unit Clinical Pharmacy (KPhz)
Implementation of patient-oriented pharmacy in teaching, research and routine care to improve medication safety 

Drug Utilisation and Drug Safety (AAS)
Supporting clinicians in providing individualized, effective, and safe drug therapy through drug information service and ward round accompaniement  

Medical Information Technology (MedIT)
Operation and development of electronic drug information systems to provide comprehensible information from electronic data sources; transformation of medical knowledge into electronic data sources 

Pharmacoepidemiology
(PhEpi)
Characterization of patient and drug utilization patterns to increase the effectiveness and safety of drug therapy for special populations or individual patients through treatment individualization 

Human Resources, Finance and Quality Management (PFQ)
Comprehensive administrative support of the department including Quality Management, IT Services, Scientific Project Management and Scientific Writing